David Jung

2.6k total citations
35 papers, 1.5k citations indexed

About

David Jung is a scholar working on Molecular Biology, Organic Chemistry and Molecular Medicine. According to data from OpenAlex, David Jung has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Molecular Medicine. Recurrent topics in David Jung's work include Antimicrobial Peptides and Activities (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Bacterial biofilms and quorum sensing (4 papers). David Jung is often cited by papers focused on Antimicrobial Peptides and Activities (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Bacterial biofilms and quorum sensing (4 papers). David Jung collaborates with scholars based in United States, Canada and Germany. David Jung's co-authors include Robert E. W. Hancock, Mark Okon, Annett Rozek, Samuel J. Danishefsky, John J. Masters, Martin J. Di Grandi, Suzana K. Straus, William G. Bornmann, Cheryl A. Alaimo and Wendy B. Young and has published in prestigious journals such as Journal of the American Chemical Society, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

David Jung

35 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Jung United States 21 652 538 234 205 191 35 1.5k
Jason A. Moss United States 16 155 0.2× 720 1.3× 123 0.5× 46 0.2× 94 0.5× 28 1.2k
Walter E. DeWolf United States 26 620 1.0× 984 1.8× 147 0.6× 163 0.8× 190 1.0× 50 1.9k
David F. Corbett United Kingdom 19 286 0.4× 662 1.2× 217 0.9× 51 0.2× 62 0.3× 47 1.4k
Predrag Čudić United States 19 298 0.5× 691 1.3× 185 0.8× 58 0.3× 350 1.8× 48 1.1k
Natalia Calonghi Italy 22 465 0.7× 664 1.2× 67 0.3× 93 0.5× 178 0.9× 67 1.5k
Shinichi Miyairi Japan 22 260 0.4× 794 1.5× 68 0.3× 97 0.5× 122 0.6× 70 1.5k
Hak Sung Kim South Korea 26 457 0.7× 878 1.6× 143 0.6× 107 0.5× 10 0.1× 74 1.8k
Richard Silverstein United States 20 151 0.2× 499 0.9× 81 0.3× 90 0.4× 98 0.5× 43 1.5k
Massimo Pregnolato Italy 22 527 0.8× 693 1.3× 79 0.3× 70 0.3× 46 0.2× 78 1.6k
Terry W. Moore United States 23 402 0.6× 1.0k 1.9× 94 0.4× 142 0.7× 49 0.3× 61 1.6k

Countries citing papers authored by David Jung

Since Specialization
Citations

This map shows the geographic impact of David Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jung more than expected).

Fields of papers citing papers by David Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jung. The network helps show where David Jung may publish in the future.

Co-authorship network of co-authors of David Jung

This figure shows the co-authorship network connecting the top 25 collaborators of David Jung. A scholar is included among the top collaborators of David Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Jung. David Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeczycki, Tonya N., et al.. (2022). 2-Aminoimidazole Analogs Target PhoP Altering DNA Binding Activity and Affect Outer Membrane Stability in Gram-Negative Bacteria. Biochemistry. 61(24). 2948–2960. 3 indexed citations
2.
Jung, David, et al.. (2019). What Was the Name of That Drug? How Medical Students can Make the Most Out of Their Education. SHILAP Revista de lepidopterología. 7(2). 50–51. 1 indexed citations
3.
Jung, David, et al.. (2019). How safe are our studies? Analysis of adverse events in Bayer First-in-Human trials from 2006 to 2016. International Journal of Clinical Pharmacology and Therapeutics. 58(1). 10–20. 2 indexed citations
4.
5.
Jung, David, et al.. (2018). New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii. ACS Infectious Diseases. 4(9). 1368–1376. 32 indexed citations
6.
Pimenta, Eduardo, Markus Jensen, David Jung, et al.. (2017). Abstract 15196: A Novel Balanced Dual Vasopressin V1a/V2 Receptor Antagonist for Treatment of Congestive Heart Failure: Results From a First-in-Man Study. Circulation. 1 indexed citations
7.
Cheung, Mui, Philip A. Harris, Stanley D. Chamberlain, et al.. (2008). The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5428–5430. 36 indexed citations
8.
Scott, Walter R. P., Seung Bin Baek, David Jung, Robert E. W. Hancock, & Suzana K. Straus. (2007). NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(12). 3116–3126. 54 indexed citations
9.
Jung, David, Jennifer R. Calhoun, James D. Lear, et al.. (2007). Effect of divalent cations on the structure of the antibiotic daptomycin. European Biophysics Journal. 37(4). 421–433. 90 indexed citations
10.
Lackey, Karen, Octerloney B. McDonald, Edgar R. Wood, et al.. (2006). Discovery and in vitro Evaluation of Potent Kinase Inhibitors: Pyrido[1′,2′:1,5]pyrazolo[3,4‐d]pyrimidines.. ChemInform. 37(4). 1 indexed citations
11.
Bamford, Mark J., Nicholas Bailey, Susannah Davies, et al.. (2005). (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(14). 3402–3406. 30 indexed citations
12.
Lackey, Karen, Octerloney B. McDonald, Edgar R. Wood, et al.. (2005). Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1′,2′:1,5]pyrazolo[3,4-d]pyrimidines. Bioorganic & Medicinal Chemistry Letters. 15(16). 3778–3781. 28 indexed citations
13.
Stevens, Kirk L., David Jung, Mui Cheung, et al.. (2005). Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors. Organic Letters. 7(21). 4753–4756. 73 indexed citations
14.
Jung, David, Annett Rozek, Mark Okon, & Robert E. W. Hancock. (2004). Structural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin. Chemistry & Biology. 11(7). 949–957. 231 indexed citations
15.
Ayas, Najib, Sanjay R. Patel, Atul Malhotra, et al.. (2004). Auto-Titrating Versus Standard Continuous Positive Airway Pressure for the Treatment of Obstructive Sleep Apnea: Results of a Meta-analysis. SLEEP. 27(2). 249–253. 154 indexed citations
16.
Johns, Brian A., Kristjan S. Gudmundsson, Elizabeth M. Turner, et al.. (2003). Pyrazolo[1,5-a]pyridines: synthetic approaches to a novel class of antiherpetics. Tetrahedron. 59(45). 9001–9011. 48 indexed citations
17.
Stafford, Jeffrey A., Gregory J. Pacofsky, Richard F. Cox, et al.. (2002). Identification and Structure–Activity Studies of Novel Ultrashort-Acting Benzodiazepine Receptor Agonists. Bioorganic & Medicinal Chemistry Letters. 12(21). 3215–3218. 24 indexed citations
18.
Sámano, Vicente, John A. Ray, James B. Thompson, et al.. (1999). Synthesis of Ultra-Short-Acting Neuromuscular Blocker GW 0430:  A Remarkably Stereo- and Regioselective Synthesis of Mixed Tetrahydroisoquinolinium Chlorofumarates. Organic Letters. 1(12). 1993–1996. 30 indexed citations
19.
Masters, John J., David Jung, Samuel J. Danishefsky, et al.. (1995). Eine neuartige, intramolekulare Heck‐Reaktion: Synthese eines Cholesterin‐Baccatin‐III‐Hybrids. Angewandte Chemie. 107(4). 495–498. 4 indexed citations
20.
Crimmins, Michael T., David Jung, & Jeffrey J. Gray. (1992). A total synthesis of (.+-.)-bilobalide.. Journal of the American Chemical Society. 114(13). 5445–5447. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason A. Moss Breakdown of academic impact, for papers by Walter E. DeWolf Breakdown of academic impact, for papers by David F. Corbett Breakdown of academic impact, for papers by Predrag Čudić Breakdown of academic impact, for papers by Natalia Calonghi Breakdown of academic impact, for papers by Shinichi Miyairi Breakdown of academic impact, for papers by Hak Sung Kim Breakdown of academic impact, for papers by Richard Silverstein Breakdown of academic impact, for papers by Massimo Pregnolato Breakdown of academic impact, for papers by Terry W. Moore
Rankless by CCL
2026